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1. Introduction
Posttraumatic stress disorder (PTSD) is the most common mental health problem among
people exposed to traumatic events. Since its introduction into the psychiatric classification
system in the 1980s various treatments have been tested for PTSD. Meta-analyses based on
randomized controlled trials (RCTs) concluded that trauma-focused psychotherapies are most
effective treatments for PTSD [1-3]. The most widely used trauma-focused psychotherapies
are exposure treatment, cognitive therapy, cognitive behavioural treatment (CBT) involving a
combination of exposure and cognitive interventions, and Eye Movement Desensitization and
Reprocessing (EMDR). In this chapter we briefly review these treatments in terms of their
theoretical background, application, efficacy, tolerability, and length of delivery.
2. Trauma-focused psychotherapies
2.1. Exposure treatment
Exposure based interventions have the largest evidence base and received the strongest empirical
support for efficacy in treatment of PTSD as well as other anxiety disorders [4, 5]. Exposure
treatment has its theoretical foundation in learning theory of fear acquisition and extinction.
Basically, learning theory holds that fear is learned through classical conditioning and system‐
atic exposure to feared stimulus without any adverse consequence results in progressive
reduction in the fear response (i.e. extinction or habituation of fear response). The mechanism
of exposure treatment is now explained with the concept of habituation and corrective learn‐
ing in the widely known emotional processing theory developed by Foa and colleagues [6, 7].
According to this theory, fear is represented in memory as a structure consisting of informa‐
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tion about (a) the feared stimulus, (b) verbal, physiological, and motor responses, and (c) their
interpreted meaning [8, 9]. Exposure therapy exerts its effect through activation of the ‘fear
structure’ and integration of corrective information that is incompatible with it (e.g. disconfir‐
mation of overestimated probability of harm) [6]. Successful exposure therapy does not abolish
pathological associations in the fear structure, but rather establishes new, non-pathological ones
[7]. In other words, fear reduction implies new learning, not unlearning. Three indicators of
emotional processing determine successful learning and thus outcome of exposure therapy: (a)
initial fear activation (i.e. physiological arousal in response to feared stimulus), (b) within-
session habituation of anxiety (i.e. fear reduction during exposure to feared stimulus), and (c)
between-session habituation (i.e. reduction in initial fear response across sessions) [6]. Within-
session habituation helps dissociating the stimulus from fear response and between-session
habituation forms the basis for long-term learning by providing opportunities of change in the
meaning of the association between stimulus and fear response (i.e. lowered expectation of harm
and lessened valence, negativity, of the stimulus). Within-session habituation is a necessary
prerequisite for between-session habituation.
Although the contemporary learning theory provides the most validated, comprehensive, and
plausible theory of anxiety disorders [10, 11], the emotional-processing theory has received
partial support. In an extensive review of clinical studies that examined the contribution of
three indicators of learning to treatment outcome, Craske and colleagues found only weak
support for the premises of emotional processing theory [12]. The authors found no consistent
evidence to support or refute the role of initial fear activation. While within session-habituation
often occurs, the amount by which fear declines or the level of fear on which a given exposure
trial ends does not predict overall improvement. Hence, within session-habituation appears
to be mediated by mechanisms that are different than the mechanisms responsible for long-
term outcomes. Although some studies show that the amount by which fear is reduced across
occasions of exposure (between-session habituation) predicts treatment outcome, other studies
indicate that improvement occurs despite lack of significant reductions in parameters of fear
(e.g. heart rate or skin conductance) between exposure sessions. Finally, the authors found no
evidence for the premise that within session-habituation is a necessary precursor to between-
session habituation. On the basis of these findings and the literature documenting the context-
specific nature of fear extinction [13], it has been suggested that that there is a need to shift
away from an emphasis on fear reduction during exposure therapy to a new exposure
paradigm which emphasizes attenuating avoidance behaviour and strengthening anxiety and
fear tolerance [12, 14]. This is consistent with experimental work with animals which show
that unpredictable and uncontrollable stressors play an important role in the development of
anxiety and fear responses [15, 16] and the evidence from research with trauma survivors
suggesting that lack of sense of control over traumatic stressors is the critical mediating factor
in PTSD [11, 17-20]. Thus, helping the person regain control over traumatic stressors might
therefore reduce traumatic stress [15, 21].
The goal of classic exposure therapy in PTSD as practised today is to promote anxiety reduction
through habituation and emotional processing of trauma memory [22]. This is achieved by
imaginal exposure to trauma memory and live exposure to trauma reminders. In imaginal
exposure the survivor recounts anxiety evoking memories about the traumatic event in a
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systematic, prolonged and repetitive manner, while in live exposure s/he confronts anxiety
evoking reminders of the traumatic event. Most treatment protocols combine imaginal and
live exposure, while a few incorporate only imaginal exposure [23-25]. The way imaginal and
live exposure is implemented shows great variability across programmes. For instance, in the
widely used Prolonged Exposure programme developed by Foa and colleagues [26], live
exposure is introduced simultaneously with imaginal exposure and imaginal exposure is
followed by a discussion of emotional responses to trauma memory. In the Exposure Therapy
protocol of Marks and colleagues [27], on the other hand, live exposure is introduced midway
in the treatment following 5 sessions of imaginal exposure and emotional responses to trauma
memory are not discussed at any stage. Many treatment programmes that are largely based
on these two protocols also employed additional interventions such as anxiety management
techniques (e.g. relaxation training, coping skills training, breathing training, thought stop‐
ping, and guided self-dialogue) [28, 29], cognitive restructuring [30-33], supportive counselling
[23] and imagery rescripting (i.e. developing a positive alternative visual representation of
oneself coping more effectively with the trauma during and / or after its occurrence) [34, 35].
Relatively little research has been conducted to examine the contribution of these techniques
to improvement. While some evidence suggests that adding cognitive restructuring to
exposure enhances treatment effects [23], other studies show that cognitive interventions [27,
36, 37] or various anxiety management techniques [38] do not confer additional benefits when
used in combination with exposure.
Considering the problems associated with the habituation model and the findings on the
importance of sense of control in trauma survivors (reviewed above), Basoglu and colleagues
[21, 39-41] modified exposure treatment by: (a) focusing on only behavioural avoidance in
treatment (i.e. live exposure to trauma cues), thereby eliminating treatment ingredients that
rely on heavy therapist input and pose challenges of practicability in different post-disaster
and cross-cultural settings; and (b) shifting treatment focus from habituation to feared stimuli
to enhancement of ‘sense of control’ over them. The underlying principle of the new Control-
Focused Behavioural Treatment is to enhance a person’s resilience against traumatic stressors by
helping them to develop sense of control over them. This can be achieved by exposure to either
(a) unconditioned stimuli in a safe and controlled environment (i.e. the original traumatic
stressor in simulated form or in virtual reality settings) or (b) conditioned stimuli (e.g. trauma
reminders) that possess the distress-evoking characteristic of the unconditioned stimuli until
the person is able tolerate and control associated distress [42]. To this end treatment targets
behavioural avoidance of trauma reminders and mainly involves therapist-delivered instruc‐
tions for self-exposure to feared and avoided situations until the survivor is able to tolerate
and feel in control of anxiety or fear (rather than until ‘fear is reduced’). The findings from
clinical trials (reviewed below) showed that Control Focused Behavioural Treatment has promise
in treatment of mass trauma survivors.
2.2. Cognitive therapy
Cognitive therapy of anxiety disorders is based on the understanding that anxiety occurs due
to selective processing of information in the environment perceived as signalling threat or
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danger to the individual and such cognitive biases can be corrected through conscious
reasoning [43, 44]. The cognitive model of PTSD views anxiety as an outcome of maladaptive
appraisals about trauma and its consequences and attributions centring on danger and threat
[45]. In addition, traumatic events are believed to shatter people’s basic beliefs and assump‐
tions about themselves, the world, and others [46]. Therapy is thus designed to restructure or
correct dysfunctional ways of thinking that cause distress, anxiety, or fear. The survivor is
taught to challenge dysfunctional thoughts or beliefs through Socratic reasoning, test their
accuracy through behavioural experiments in situations perceived threatening or dangerous,
and replace them with alternative ones that better reflect reality.
Empirical support for cognitive theory of PTSD is rather weak. No prospective study with
pre- to post-trauma assessments tested whether traumatic events shatter basic beliefs and
assumptions. Although survivors with PTSD tend to report more negative beliefs [47-49] or
information processing biases [50-52],  there is  not sufficient evidence to refute the argu‐
ment that these may be epiphenomena of traumatic stress problems, rather than being a
cause of them. Research on this issue that employed statistical controls to examine the role
of all possible contributing factors to the disorder (e.g. demographic, personal history, trauma
exposure characteristics etc.) did not indeed find a strong association between beliefs and
PTSD  [18,  20].  Furthermore,  exposure,  though  referred  to  as  behavioural  experiment,  is
considered a necessary component of cognitive therapy for successful treatment because it
allows better processing of threat [43, 44]. As exposure’s efficacy is already established in
anxiety disorders, it is difficult to attribute successful treatment outcome in cognitive therapy
to cognitive change. Furthermore, even when treatment protocols do not directly involve an
exposure component, they may indirectly trigger it. Similarly, exposure therapy alone may
provide an opportunity to test dysfunctional appraisals about trauma and thereby lead to
cognitive change. Comparative studies found cognitive therapy as effective as exposure [27,
53, 54]. However, the fact that no study examined whether cognitive therapy instigated self-
exposure in between sessions among treated cases preclude a definitive conclusions about
the importance of cognitive change in treatment. On the other hand, there is evidence showing
that exposure treatment without cognitive restructuring produce as much cognitive change
as exposure with cognitive restructuring [37, 55, 56]. Reductions in negative cognitions were
significantly  related  to  reductions  in  PTSD  symptoms  in  these  studies,  suggesting  that
cognitive change occurs as a response to improvement in PTSD and not vice versa. These
findings support the view that cognitive responses to trauma are epiphenomena of traumat‐
ic stress.
As exposure protocols, cognitive therapy programmes for PTSD differ in their specifics. The
Cognitive Therapy programme developed by Ehlers and colleagues [57, 58] and Cognitive
Processing Therapy developed by Resick and colleagues [53] involve imaginal exposure to the
traumatic memory, but this is limited to only a few sessions and the focus of imaginal reliving
is to teach the survivor modify their beliefs about the meaning of the traumatic event. The
Ehlers et al programme also involves some unsystematic live exposure (e.g. visiting the site
where the trauma happened). Other cognitive therapy protocols do not involve any exposure
elements [24, 27].
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2.3. Eye Movement Desensitization and Reprocessing (EMDR)
The field of PTSD treatment witnessed a rapid growth of new treatment protocols, the most
studied of which is undoubtedly EMDR. EMDR is an information processing therapy during
which the patient recounts trauma story with its cognitive, affective, and physiological features
while simultaneously focusing visually on bilateral movements of an external stimulus until
the distress evoked by traumatic memory subsides [59]. The EMDR theorists maintain that the
eye movements reduce the distress associated with trauma memories and help cognitive and
emotional reprocessing of the traumatic event. EMDR combines multiple theoretical perspec‐
tives and techniques, most pronouncedly imaginal exposure and cognitive restructuring.
Proponents of EMDR hold that the very brief and interrupted nature of imaginal exposure in
EMDR sessions is at stark contrast with the behaviour therapists’ requirement of prolonged
and uninterrupted exposure to achieve habituation and disconfirmation of fear-expectancies
[5, 6]. However, research on the processes of change in exposure treatment has not been
conclusive regarding these requirements [12, 60]. EMDR proponents also contend that the use
of directed eye movements distinguishes this form of therapy from other cognitive behavioural
approaches. However, the role of eye movements in treatment has not been theoretically
clarified and the findings of dismantling studies (reviewed in a meta-analysis) suggest that the
eye movements are neither necessary nor sufficient to treatment outcome [61].
2.4. Other trauma focused interventions
Some treatment programmes for PTSD combined different components of existing treatment
protocols under a different name (e.g. Cognitive-Behaviour Trauma Treatment Protocol [62],
Trauma Focused Group Psychotherapy [32], Direct Therapeutic Exposure [33]. Some other new
protocols, on the other hand, mainly embodied some form of exposure and cognitive restruc‐
turing, but these were presented with a different rationale for efficacy and they varied in the
procedures of implementation (e.g. Narrative Exposure Therapy [63], Imagery Rehearsal Therapy
[64], Image Habituation Training [65, 66], etc.). Although they look like new treatment ap‐
proaches, these are mainly modified forms of existing treatments for PTSD. Also, few are
grounded in theories of aetiology of PTSD and related empirical support.
2.5. Evidence base of trauma-focused psychotherapies
As noted earlier, several meta-analyses of randomised controlled trials showed comparable
efficacies for various trauma-focused psychotherapies [1-3]. These meta-analyses, however,
did  not  examine  the  efficacy  of  various  treatment  packages  with  respect  to  their  main
components. Such examination is important in clarifying the ingredients that are most useful
for achieving maximum efficacy. Such knowledge also has important implications for refining
theories of PTSD. To identify the contribution of each component to treatment efficacy we
conducted  a  comprehensive  literature  review  of  randomized  controlled  trauma-focused
treatment  studies  of  PTSD.  These  studies  were  selected  through  a  literature  search  of
randomized controlled trials of CBT in PsycInfo (1806 – 2009), PILOTS (1960 – 2009), and
PubMed (1966 – 2009) databases. To be included in the meta-analysis the study must have
(a) tested the efficacy of a treatment for PTSD against a control group, waitlist or placebo
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treatment or alternative intervention, or combination of any of these, using a randomized
controlled trial design, (b) included adults who met diagnostic criteria for acute (1 to 3 months
post-trauma) or chronic (more than 6 months post trauma) PTSD as defined by DSM-III,
DSM-IIIR, DSM-IV, or DSM-IVTR, (c) used valid structured interview forms and / or self-
rated instruments for the assessment of PTSD, (d) its sample size was large enough to allow
sufficient power in analyses (i.e. at least 8 patients in each group), (e) provided sufficient
data in the article for calculation of effect sizes or through contact with authors, and (f) has
been published in English. This search revealed 41 studies that met the inclusion criteria. We
analysed them meta-analytically by combining their findings using the standardised effect
size statistic. Effect size is a measure of the strength or magnitude of a treatment effect and
one way to calculate it is by computing the difference between pre- and post-treatment means
on outcome measures and dividing this by the pooled standard deviation of those means
[67].  This  method  can  also  be  used  to  calculate  the  effect  size  between  two  treatment
conditions.  Effect  size values of  0.20 indicate  small,  0.50 moderate,  and 0.80 large treat‐
ment effects. Larger effect sizes indicate more symptom reduction and less residual symp‐
toms at the end of treatment. As various clinician-rated and / or self-rated instruments were
used to assess PTSD we computed an aggregate effect size over all  PTSD measures em‐
ployed in a study. Data were analysed using SPSS 14.
Table 1 shows the number of participants, attrition rates, treatment duration (number of
sessions and total hours spent), and effect sizes for PTSD and depression from baseline to post-
treatment for main treatment components of 41 randomized controlled trials. Studies involv‐
ing Control-Focused Behavioural Treatment [21] are excluded from this meta-analysis due to its
theoretical difference from other treatment protocols and brevity (i.e. single-session applica‐
tion). These studies are reviewed separately in Section 2.6. Treatments in Table 1 were tested
with survivors from a wide range of trauma events, including war veterans, rape victims and
survivors of childhood abuse, survivors of civilian trauma (e.g. physical assault, crime, traffic
accident, etc.), and refugees. Exposure-based interventions were tested with all these trauma
survivors, whereas cognitive treatments and EMDR were mainly tested with survivors of rape
and civilian trauma. Control conditions involved waiting list and non-specific treatments such
as relaxation, supportive counselling, and present-centred therapy (i.e. coping and problem
solving skills training).
N conditions Sample
Size
Attrition
rate
N
sessions
Treatment duration Effect sizea
Mean (SD)
Main
treatment
components
% Mean
(range)
Hours
Mean (SD)
Weeks
Mean
(Range)
PTSD
Imaginal
exposure1
6 105 20 8.5 (4-14) 11.8 (6.6) 9 (3-23) 0.86 (0.39)
Imaginal + live
exposure2
11 317 25 10 (5-20) 16.5 (9.2) 9 (4.5-16) 1.98 (0.69)
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N conditions Sample
Size
Attrition
rate
N
sessions
Treatment duration Effect sizea
Mean (SD)
Main
treatment
components
% Mean
(range)
Hours
Mean (SD)
Weeks
Mean
(Range)
PTSD
Imaginal
exposure +
cognitive
restructuring3
4 165 20 17 (8-30) 29.6 (21.7) 17 (9-30) 1.29 (1.11)
Live exposure
+ cognitive
restructuring4
2 64 16 11 (--) 16.5 (0.0) 5.5 (--) 3.80 (0.83)
Imaginal + live
exposure +
cognitive
restructuring5
10 193 32 11 (4-20) 18.5 (9.9) 12 (4-18) 1.74 (0.48)
Cognitive
therapy
without
exposure6
2 51 8 11 (10-12) 13.5 (2.1) 21 (16-26) 1.41 (0.35)
Cognitive
therapy with
limited
imaginal / live
exposure7
4 107 19 16 (12-27) 18.1 (11.6) 12 (6-17) 2.42 (0.67)
Imaginal & live
exposure +
anxiety
management8
2 34 17 8 (7-9) 12.0 (2.1) 6 (5-7) 1.78 (0.30)
Imaginal
exposure +
skills training9
2 33 32 25 (16-34) 37.5 (19.1) 15 (12-17) 1.16 (0.87)
Imaginal
exposure +
imaginal
rescripting10
2 76 31 6.5 (3-10) 11.0 (5.7) 7.5 (5-10) 1.09 (0.31)
EMDR11 12 199 16 6 (2-12) 8.5 (4.6) 6 (2-10) 1.66 (0.94)
Control
Conditions
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N conditions Sample
Size
Attrition
rate
N
sessions
Treatment duration Effect sizea
Mean (SD)
Main
treatment
components
% Mean
(range)
Hours
Mean (SD)
Weeks
Mean
(Range)
PTSD
Relaxation12 4 59 11 10 (8-12) 11.7 (3.5) 10 (6-16) 0.75 (0.61)
Supportive
counseling13
4 66 18 8 (5-10) 11.4 (3.0) 6 (4-10) 0.60 (0.32)
Present
centered
therapy14
3 268 18 18 (9-30) 27.8 (15.8) 20 (10-30) 0.70 (0.48)
Treatment as
usual15
2 47 7 -- -- -- 0.69 (0.58)
Waitlist /
minimal
attention
control16
25 516 11 -- -- -- 0.27 (0.38)
a Calculated from the raw data reported in the articles. Where data were provided only in graphic form, raw data were
obtained from the authors. For articles reporting effect sizes without reporting any data, effect sizes as reported in the
published article were used.
1= [23, 25, 34, 54, 63, 65], 2 = [26, 27, 36-38, 53, 89, 107-110], 3 = [23, 32, 33, 111], 4 = [112, 113], 5 = [27, 30, 31, 36, 37,
62, 114-117], 6 = [27, 54], 7 = [53, 57, 118, 119], 8 = [29, 38], 9 = [28, 33], 10 = [34, 64], 11 = [29, 62, 65, 108, 110, 116,
120-125], 12 = [27, 65, 110, 120], 13 = [23, 26, 63, 114], 14 = [32, 115, 126], 15 = [31, 123], 16 = [25, 26, 28, 30, 33, 36,
38, 53, 57, 63, 64, 89, 108, 111-116, 118-122, 124]
Table 1. Evidence base for trauma-focused interventions
All active treatments yielded larger effects on PTSD than did control conditions. Although all
treatments achieved clinically large effect sizes (over 0.80) in PTSD, they differed in their
efficacy. Imaginal exposure and cognitive therapy had limited efficacy compared with other
treatments when they were used alone. Although the addition of cognitive restructuring, skills
training, and imagery rescripting enhanced the efficacy of imaginal exposure, treatment effects
still remained limited. On the other hand, the efficacy of both imaginal exposure and cognitive
therapy reached their maximum when they were combined with live exposure (1.98 and 3.80,
respectively). These findings imply that live exposure is the critical ingredient in CBT packages.
Cognitive therapy programmes involving an exposure component also performed signifi‐
cantly better than cognitive therapy alone, suggesting that cognitive interventions by them‐
selves are not sufficient for successful treatment outcome. The addition of other interventions
to full exposure programmes did not lead to better outcomes (they even compromised
treatment gains). EMDR was also effective in PTSD, however it was associated with more
residual symptoms than the potent forms of exposure based treatments with or without
New Insights into Anxiety Disorders386
cognitive restructuring. It is also noteworthy that the evidence base for exposure treatments
involves more methodologically rigorous studies than that of EMDR.
It is worth noting that the effect sizes reported in Table 1 are based on cases that completed a
given programme during a RCT. As 8% to 32% of the patients dropped out of the studies, the
composition of the experimental groups can no longer be considered random, which creates
a selection bias reflecting the outcome of those who remain in the study or who respond to the
specific treatment [68]. Findings based on more conservative intent-to-treat (or last observation
carried forward) analyses, which include non-treated or non-treatment-responder cases, are
more attenuated. For example, the effect sizes for imaginal and live exposure and cognitive
therapy with limited exposure programmes in studies that reported intent-to-treat analyses
were 1.23 (n = 4) and 1.80 (n = 3), respectively. We selected to report findings based on
completers analyses because we were interested in seeing treatment outcome among those
who received the full treatment. Also, intent-to-treat analyses were not consistently reported
in all articles.
Tolerability of a treatment as indicated by attrition rates is an important parameter in evalu‐
ating treatment protocols. Attrition rates varied across treatment protocols but the differences
were not statistically significant. When we grouped interventions, the average rate of drop-
out was 25% from treatment packages involving an exposure component (including cognitive
therapy with limited exposure), 8% from cognitive therapy and, 16% from EMDR. Although
it seemed that interventions involving exposure were less tolerable, this finding needs to be
cautiously interpreted because they were examined in a total of 43 trial conditions compared
with only 2 cognitive therapy and 12 EMDR conditions. In addition, the number of participants
in exposure was 5.5 to 21 times higher than those in EMDR and cognitive therapy (1094 vs 199
and 51, respectively).
Treatments showed great variability with respect to number of sessions and time to recovery
they required. Interventions involving exposure and cognitive therapy were delivered in a
mean 12 sessions, while EMDR was administered in an average of 6 sessions. Treatment lasted
an average of 16 hours (SD = 11) in exposure, 20 (SD = 12) hours in exposure with cognitive
interventions, 13.5 (SD = 2.1) in cognitive therapy, and 8.5 (SD = 4.6) in EMDR. Treatment
delivery in these interventions took a mean of 9 (SD = 5), 12 (SD = 6), 21 (SD = 7), and 6 (SD =
3) weeks, respectively. Although delivered in about the same number of sessions, cognitive
interventions required more time in treatment than did exposure alone. Cognitive therapy
alone achieved relatively limited effects in a longer period of time than did all other treatments.
EMDR appeared to be the briefest treatment.
Treatment programmes reported in Table 1 vary in their complexity for training. Although
practice varies, more complex treatment programmes require more time for training and
supervision and they are therefore more difficult to disseminate. There is not much informa‐
tion on the duration of various training programmes. The most common exposure protocol
used with trauma survivors, prolonged exposure [26] and cognitive therapy [58] require 5
days  of  training  each  [36].  Combined  treatments  take  longer  time  for  training.  EMDR
Institute’s  website  states  that  EMDR basic  training is  completed in  40  hours  and 2-day
workshops are held for advanced training. The complex procedures involved in conduct‐
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ing  imaginal  exposure  and  cognitive  restructuring  pose  challenges  in  training  of  lay
therapists. All these treatments also require continuous supervision. Furthermore, they rely
on heavy therapist input and as such they are not suitable for dissemination on a self-help
basis.
The cross-cultural applicability of these interventions is largely unknown as they were mostly
tested in western countries. As exposure therapy targets universals of human behaviour (fear
and avoidance) it would be expected to have promise in different cultural settings. On the other
hand, it is difficult to make predictions about cognitive interventions, because cross-cultural
validity of the so called maladaptive / faulty thinking patterns about trauma and its sequelae is
not known. Furthermore, requirements of keeping homework sheets [26, 53] and heavy writing
tasks involved in some treatment protocols [53] may complicate their practicability among
survivors with low level of education that characterize populations of developing countries.
They also pose challenges of use under difficult post-disaster or post-war settings, where
survivors deal with day-to-day survival problems. Finally, the efficacy of these treatments has
rarely been examined in survivors of natural disasters and war.
2.6. Control-focused behavioural treatment
Control-Focused Behavioural Treatment was tested in two open and two randomized clinical trials
involving 331 earthquake survivors with chronic PTSD. In an open trial [39], among survivors
with a PTSD diagnosis, the probability of clinically significant improvement was 76% after one
session and 88% after two sessions, reaching 100% after four sessions. This improvement
corresponded to a mean 57% reduction in PTSD symptoms, 69% in fear and avoidance behav‐
iours, and 50% in depression. The mean number of sessions required for improvement was 1.7.
In a subsequent randomized controlled trial Control-Focused Behavioural Treatment achieved
improvement in 80% of survivors when delivered in a single session [40]. In the latter study,
behavioural avoidance was the first symptom to improve early in treatment (6 weeks), fol‐
lowed by improvement in re-experiencing and hyperarousal symptoms [69]. Thus, reduction
in avoidance appeared to be the critical factor that initiated the process of improvement in other
symptoms. Further studies showed that treatment effect could be enhanced by 20% by an
additional session involving therapist aided exposure to simulated earthquake tremors in an
earthquake simulator [41, 70]. Improvement was maintained in the long-term in all studies,
despite further exposure to numerous aftershocks and expectations of another major earth‐
quake. An average of 6 sessions of Control-Focused Behavioural Treatment  achieved similar
improvement rates in asylum-seekers and refugees in Turkey, despite adverse psychosocial and
economic circumstances [21, 71]. These findings suggested that Control-Focused Behavioural
Treatment has promise in treatment of mass trauma survivors in non-western settings. The single-
session application of Control-Focused Behavioural Treatment, which emphasizes self-conducted
exposure in survivors’ daily routine, has promise of easy distribution to large number of survivors
in mass disaster settings. Further studies are needed to confirm these findings in different trauma
populations living in different cross-cultural settings.
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3. Pharmacotherapy of PTSD
According to pathophysiological theories, PTSD symptoms occur as an outcome of excessive
activation of the amygdala by stimuli that are perceived to be threatening. The key psychobio‐
logical systems that are believed to be altered in PTSD are adrenergic, hypothalamic-pituitary-
adrenocortical  (HPA),  glutametergic,  serotenergic,  and  dopaminergic  systems.  Various
pharmacological agents therefore aim to intervene disruptions in these systems. Before 2000 a
handful of randomized controlled trials reported some beneficial effects of tricyclic antidepres‐
sants. With the introduction of Selective Serotonin Reuptake Inhibitors (SSRI) in the treatment of
anxiety disorders, researchers lost interest in studying these medications because SSRIs had
more tolerable side effects and pharmaceutical companies are more eager to provide funding
for research on these medications [72]. SSRIs are now indicated as the pharmacotherapy of choice
in several clinical practice guidelines for PTSD [72-74]. Recently, the efficacy of newer antidepres‐
sants,  including  serotonin-norepinephrine  reuptake  inhibitors  (SNRIs,  venlafaxine)  and
noradregenic and specific serotonergic agents (NaSSA, mirtazaine) has also been examined. In
addition, some atypic antipsychotic medications (risperidone and olanzapine) have been tested
as adjunctive agents for refractory patients who have failed to respond to antidepressants. In
this section we review the evidence from double-blind placebo controlled randomized clinical
trials of SSRIs, SNRIs, NaSSa, and atypical antipsychotics. These agents are selected for the review
because other drugs (e.g. anticonvulsant / antikindling agents, monoamine oxidase inhibitors,
etc.) have been mostly tested in case studies or open label trials. Benzodiazepines are not included
in the review because they were not found to be effective in PTSD [72]. The same methodology
described above for trauma-focused therapy protocols was followed.
Table 2 lists 21 studies that tested the efficacy of antidepressants and antipsychotics combined
with antidepressants in double-blind placebo controlled randomized controlled design.
Treatment duration varied between 4 to 16 weeks. The attrition rates for drug and placebo
were 31% (SD = 7%, range 13-47%) and 29% (SD = 14%, range 0-59%), respectively. These figures
were slightly higher than those reported in psychotherapy trials. Mean reduction in PTSD
symptoms was 38% (SD = 16.5) in cases treated with active drugs, while it was 28% (SD = 14.1)
in cases given pill placebo. Thus, drug-placebo difference was only 10%. This pattern of
improvement was also noted in effect sizes (these were calculated using change scores as
described by Kazis et al. [75], because drug trials did not always report post-treatment scores).
Although the majority of the drugs achieved large pre- to post-treatment effects, so did the pill
placebo. Indeed, the between-treatment effect sizes rarely exceeded the threshold (i.e. 0.50)
necessary to detect a clinically significant difference between an active drug and placebo. This
is in contrast with exposure-based treatments which yielded much larger effect sizes. It is worth
noting, however, drug trials based their findings on all cases that completed at least one
assessment after baseline, thus including the cases that dropped-out from treatment by
carrying their last observation forward in the data set. Even though this conservative analysis
strategy may counteracted drug efficacy compared to trauma-focused psychological treat‐
ments, evidence shows that treatment effects are more stable in the latter. There are no studies
that examined relapse rates in drug-free follow-ups. Few double-blind placebo controlled
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maintenance studies involving survivors treated with SSRIs found that discontinuation of
drug treatment is associated with return of PTSD symptoms [76-78].
The augmentation of antidepressant treatments with atypical antipsychotics in treatment
refractory patients did not also result in better outcomes, except for one study which involved
only a small number of survivors. Antidepressant treatment (paroxetine) did not also augment
treatment effects in patients who remained symptomatic after 12 weeks of exposure treatment
[79](not listed in Table 2). On the other hand, adding exposure treatment to SSRI treatment
conferred additional benefits in patients who did not respond to previous pharmacotherapy
[80, 81].
A problem concerning pharmacotherapy clinical trials in PTSD is that the findings have limited
generalizability because most studies involved middle-aged females sexually abused as
children or Vietnam Veterans [72]. There is also less evidence on the efficacy of medications
in different age groups, because concerns about increased suicides among children and
adolescents treated with SSRIs for depression and concerns about safety, age-related pharma‐
cokinetic capacity, drug-drug interactions, and comorbid medical conditions in elderly people,
Drug Placebo Drug vs
Placebo
N
studies
n %
Changeb
Effect Size
Mean (SD)
n %
Changeb
Effect Size
Mean (SD)
Effect Size
Mean (SD)
Sertraline1 5 471 36 1.54 (0.69) 474 29 1.30 (0.63) 0.31 (0.20)
Fluoxetine2 5 464 44 2.35 (0.38)c 245 32 1.83 (0.39)c 0.62 (0.37)d
Paroxetine3 3 541 44 1.77 (0.69) 363 30 1.22 (0.41) 0.57 (0.31)
Venlafaxine4 2 340 57 3.16 (0.54) 347 48 2.61 (0.40) 0.48 (0.04)
Mirtazapine5 1 17 35 1.06 (--) 9 17 0.86 (--) 0.60 (--)
Risperidone
augmentation6 4 67 26 0.99 (0.60) 63 21 0.87 (0.44) 0.26 (0.53)
Olanzapine
augmentation7 1 10 17 0.67 (--) 9 3 0.16 (--) 0.75 (--)
a Effect sizes calculated from the raw data reported in the articles. Within group effect sizes calculated as mean change
score divided by the standard deviation of the baseline score. Between-groups effect sizes were calculated as mean
change score between drug and pill placebo groups divided by standard deviation of the baseline score for placebo
group.
b Percent reductions in PTSD symptoms pre- to post-treatment
c Within treatment effect sizes for one study (van der Kolk et al, 1994) were not available and thus excluded.
d Drug vs placebo effect size for one study (van der Kolk et al, 1994) taken from [127]
1 = [128-132], 2 = [125, 133-136], 3 = [137-139], 4 = [132, 140], 5 = [141], 6 = [142-145], 7 = [146]
Table 2. Effect sizes in double-blind randomized controlled trials of pharmacotherapy for PTSDa
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pose obstacles to pharmacotherapy research in these populations [72]. Finally, when used in
combination with exposure-based treatments, drugs may undermine the efficacy of the latter
by facilitating attributions of improvement to the tablets rather than to personal efforts. In view
of these findings, use of antidepressants as a first-line intervention in treatment of trauma
survivors could hardly be justified.
4. Other psychological treatments
There are various other interventions used with trauma survivors, which vary greatly in their
emphasis in treatment. Some of these treatments aim to increase general well-being of
survivors (e.g. psychosocial support, psychoeducation, normalisation, art therapy or other
expressive recreational activities, etc.) or alleviate general psychological distress (e.g. coping
skills training, affect management, counselling, family therapy, etc.), while others target
specific psychopathology such as PTSD and depression (e.g., interpersonal psychotherapy,
school based intervention for children, brief eclectic psychotherapy, etc.). Most of these
treatments involve a mixture of diverse interventions without a well-defined theoretical
framework. This is an important problem because a treatment could only achieve partial effects
unless its mechanisms of action match the causal processes that underlie a mental health
problem [82]. Furthermore, as they do not specifically target trauma induced anxiety and fear
reactions, many treatments achieve low improvement rates. One example of such treatments
is school-based intervention programme developed for children. This treatment mainly
involves psychoeducation, normalisation of trauma reactions through creative-expressive
activities (e.g. play, art therapy), and skills training. Two RCTs that tested the efficacy of this
intervention in child survivors of war in Bosnia [83] and political violence in Indonesia [84]
found only small to moderate treatment effects in PTSD symptoms compared to waitlist
controls (effect sizes = 0.22 and 0.51, respectively). Similar moderate treatment effects were
obtained in other RCTs of a psychosocial intervention program for female survivors of war in
Bosnia [85] and an affect management treatment in child sexual abuse survivors [86].
A misplaced focus in treatment also occurs when specific psychiatric disorders other than
PTSD are targeted. The findings of two RCTs are cases in point. In one of the studies [87],
depressive symptoms were targeted with group interpersonal psychotherapy and creative
play in Ugandan adolescent war survivors. Creative play showed no effect on depression
severity, while interpersonal group psychotherapy reduced depression in girls but not in boys.
Neither treatment resulted in significant improvement in anxiety, conduct problems, and
psychosocial functioning. Targeting depression with a self-management treatment also failed
to reduce depression, PTSD, and psychosocial functioning in adult male veterans [88]. These
limited treatment effects could be explained by a misplaced focus in treatment.
There is some evidence suggesting that trauma focused psychodynamic therapy and brief
eclectic psychotherapy combining psychodynamic therapy with cognitive restructuring and
imaginal exposure are effective in PTSD. In three RCTs, compared to waitlist controls, these
treatments achieved medium to large treatment effects in PTSD symptoms (range 0.66-0.94)
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[89-91]. Methodological problems preclude definitive conclusions about the effects of these
treatments.  It  is  also  worth  noting  that  treatment  was  delivered  in  16  to  20  sessions.
Considering that exposure based treatments achieve higher treatment effects when deliv‐
ered in a mean of 12 sessions, the usefulness of psychodynamic or eclectic approaches become
questionable.
A widely used treatment approach for refugees and survivors of torture in rehabilitation
centres around the world is multi-disciplinary treatment, including social, legal, medical, and
psychological aid for survivors. An open outcome evaluation study based on 55 persons
admitted to the Research Centre for Torture Victims in Denmark in 2001 and 2002 showed no
improvement in PTSD, depression, anxiety or health-related quality of life after 9 months of
treatment, leading the authors to conclude that future studies are needed to explore effective
interventions for traumatised refugees [92]. In a more recent non-random quasi experimental
study of torture survivors in Nepal, multi-disciplinary treatment reduced non-specific somatic
problems related to torture, but not more severe specific mental health problems, including
PTSD and depression, and associated disability [93]. The authors concluded that evidence-
based treatments that are able to address specific mental health problems and associated
disability need to be investigated for torture survivors.
5. Interventions to prevent the development of PTSD
5.1. Critical incident stress debriefing
Critical Incident Stress Debriefing has been a widely used psychological intervention after
mass trauma events. In this approach survivors exposed to similar traumatic experiences
participate in a structured session where they talk about the traumatic event in detail. This
session, which takes place soon after the trauma, is said to allow venting of survivors’ emotions
about the traumatic incident within the context of psychosocial support from others and
attenuate the intensity of acute stress reactions, thereby reducing the risk of developing PTSD
[94]. Two RCTs with individual trauma survivors [95, 96] and one RCT with deployed soldiers
[97] did not find beneficial effects of debriefing in preventing or improving PTSD symptoms.
These findings led major clinical guidelines for Acute Stress Disorder (ASD) and PTSD not to
recommend the use of debriefing following traumatic events [73, 98].
5.2. Brief CBT
Condensed forms of treatment based on cognitive-behavioural principles have been tested in
survivors with ASD (i.e. within 1-month post-trauma) or acute PTSD (i.e. within 3 months
post-trauma). Treatment packages, usually delivered in 4 to 5 sessions, involved psychoedu‐
cation; breathing, relaxation, anxiety management training; cognitive restructuring; imaginal
and live exposure. A meta-analysis of the efficacy of these interventions in ASD with respect
to control groups is reported in Table 3. The latter included repeated assessment (1 study),
supportive counselling (5 studies), and waiting list (1 study). As the outcome was similar across
all controls they were pooled for the meta-analysis. Brief CBT and prolonged exposure
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(imaginal + live exposure) achieved large treatment effects in PTSD severity and moderate
effects in depression both at post-treatment and 6-months post-trauma. More survivors in the
control groups met diagnostic criteria for PTSD at post-treatment and follow up. It is worth
noting that the effect sizes in Table 3 are based on those who completed treatment and more
conservative intent-to-treat analyses do not always yield favourable outcome for treatment
[99]. Also, between-groups differences disappeared at follow-up in some studies [100]. The
generalizability of these findings is limited because they are mainly based on survivors of
assault and traffic accident. Furthermore, although treatment is relatively brief, the applica‐
bility of a 5-session treatment following mass trauma events is questionable. Nevertheless,
these findings suggest that brief exposure-based interventions delivered early after the trauma
accelerate recovery process in survivors and prove effective in preventing chronic PTSD.
Post-Treatment Follow-up
N
conditions
n
Treatment
n
Control
Effect Size PTSD diagnosis
(Tx vs control)
Effect Size PTSD diagnosis
(Tx vs control)
Acute Stress Disorder
Brief CBT1 4 58 56 1.21 8-13% vs 46-83% 0.83 10-22% vs
22-67%
Imaginal + live exposure2 3 54 53 1.13 12-14% vs
56-71%
1.15 15% vs 67%
Cognitive restructuring3 1 23 21 0.59 52% vs 71% -- --
Acute PTSD
Brief CBTa, 4 -- 76 76 0.30 30% vs 30% 0.61 10% vs 15%
Brief CBT5 -- 61 52 0.63 38% vs 61% 0.34 26% vs 44%
Cognitive restructuring +
coping skills training6
-- 10 10 0.82 20% vs 50% 1.03 0 vs 20%
Effect Size = between-groups Cohen’s d effect size index
a Effect sizes reflect outcome in intent-to-treat analyses.
1 = [99-102], 2 = [23, 103, 147], 3 = [147], 4 = [104], 5 = [148], 6 = [149]
Table 3. Efficacy of brief cognitive-behavioural treatment programmes in ASD and Acute PTSD in randomised
controlled trials
Treatment outcome in early intervention studies of acute PTSD was not as good as that
obtained in studies of ASD. Table 3 also shows findings from 3 RCTs. These studies are
examined separately because their findings were not consistent, probably due to the fact that
one study reported only intent-to-treat data. Compared to waiting list groups two studies of
brief CBT found only small to moderate treatment effects in PTSD and small effect in depres‐
sion at both post-treatment and follow-up (conducted about 6 to 13 months post-trauma). More
favourable treatment effects were obtained with cognitive restructuring combined with coping
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skills training relative to relaxation control, however this study was based on a very small
sample.
Interestingly, early interventions produced greater reductions in avoidance behaviour and,
whereas significant improvement occurred in reexperiencing and arousal symptoms, negligi‐
ble reductions occurred on avoidance symptoms in control groups [99, 101-104]. These findings
points to the important role played by avoidance symptoms in the maintenance of PTSD. More
studies need to be conducted on diverse survivor populations and different cultural settings.
5.3. Propranolol
It has been proposed that the beta-adrenergic antagonist propranolol may have promise in
preventing the later development of PTSD by reducing enhancement of traumatic memories.
Two RCTs that tested this hypothesis yielded inconsistent results. In one of these studies [105]
41 emergency department patients who had experienced a trauma likely to precipitate PTSD
were treated orally with 40 mg of propranolol within six hours of the occurrence of the
traumatic event. The drug dose was repeated four times daily for 10 days, with a nine-day
taper period. After one month, 18% (2 / 11) of propranolol completers met diagnostic criteria
for PTSD, in contrast to 30% (6 / 20) of placebo completers. The drop-out rate from propranolol
and placebo was 39% and 13%, respectively. In the other study [106] 48 acute physical injury
patients admitted to a surgical trauma centre were randomised to receive propranolol, the
anxiolytic anticonvulsant gabapentin, or placebo within 48 hours of trauma. Although well
tolerated, neither drug showed a significant benefit over placebo on posttraumatic stress
symptoms or depressive symptoms. It is worth noting that 92% of the acutely injured patients
refused to participate in the study, in part reflecting their reluctance to receive medication.
These inconsistent findings on treatment efficacy considered together with high drop-out rate
and refusal to take the medication suggest that medication is not a viable preventative option
for PTSD.
6. Conclusion
In this chapter we reviewed critically current treatment approaches for PTSD. The evidence in
the literature clearly shows that trauma-focused psychotherapies are the first line of choice in
the treatment of PTSD. The question remains as to which trauma-focused treatment protocol
is the best option. Exposure therapy involving live exposure and cognitive therapies incorpo‐
rating an exposure component are the more efficacious treatments for PTSD. Exposure therapy
has several advantages over cognitive therapy. Its theoretical background is more robust and
experimentally validated than cognitive therapy. It also has larger evidence base, was tested
with a wider range of trauma survivors, and has more promise in cross-cultural applicability.
Furthermore, cognitive therapy involves elaborate procedures that require substantial training
in its administration. Finally, exposure therapy requires relatively less time for observable
improvement.
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Despite these advantages exposure therapy is not without problems. About 40% to 50% of
patients fail to achieve clinically significant improvement after exposure therapy. These
modest improvement rates could be explained by a strong focus on anxiety reduction, rather
than anxiety tolerance, which may be counterproductive in treatment. Indeed, the evidence
indicates that the degree by which fear reduces or the level of fear following exposure is not
related to treatment outcome. Furthermore, exposure therapy is not sufficiently brief for use
in mass disaster settings. Although the procedures involved in exposure do not require lengthy
and costly training compared to other treatments, they are not suitable for delivery on a self-
help basis. There is thus need for a simple and brief intervention that emphasises anxiety / fear
tolerance and that can be easily delivered to masses. Control-Focused Behavioural Treatment has
promise in meeting this need. This short and effective treatment, which emphasizes self-
conducted exposure in survivors’ daily routine with an aim to increase anxiety tolerance and
promote resilience, is suitable for easy distribution to large number of survivors in mass
disaster settings.
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